This compound is a pharmaceutical intermediate featuring a pyrrolidine core with multiple stereocenters and a complex polycyclic structure incorporating a pyrrolopyrimidine moiety. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1190393-25-9
1-(3,5-Dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone
Pharmaceutical intermediate for sarolaner synthesis
(3aR,4R,6R,6aR)-4-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-6-(hydroxymethyl)-2,2-dimethyl-6,6a-dihydro-3aH-furo[3,4-d][1,3]dioxole-4-carbonitrile
pharmaceutical intermediate
2-(3-((4-((Ethoxyimino)methyl)-5-(4-(trifluoromethoxy)phenyl)isoxazol-3-yl)methoxy)phenyl)acetic acid
pharmaceutical intermediate
1-(4-Aminobenzyl)-1,2,4-triazole
Pharmaceutical intermediate
Beova
beta3-adrenergic receptor agonist
tert-butyl (2R,5S)-2-[(R)-hydroxy(phenyl)methyl]-5-[[4-[[(6S)-4-oxo-7,8-dihydro-6H-pyrrolo[1,2-a]pyrimidine-6-carbonyl]amino]phenyl]methyl]pyrrolidine-1-carboxylate
PWBHEFGQKRGUEV-HLPJKERBSA-N
CC(C)(C)OC(=O)N1[C@@H](CC[C@@H]1[C@@H](C2=CC=CC=C2)O)CC3=CC=C(C=C3)NC(=O)[C@@H]4CCC5=NC=CC(=O)N45
—